Compare · head to head
Bora Pharmaceuticals vs Hanall Biopharma
Hanall Biopharma ranks higher overall — 360 rank 30 vs 27.
Bora Pharmaceuticals leads on Value (46 vs 40) and Quality (56 vs 36). Hanall Biopharma leads on Safety (41 vs 32) and Sentiment (64 vs 44). The two are close on Growth.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Taiwan | South Korea |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Medium | Small |
| ISIN | TW0006472004 | KR7009420001 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 27 | 30 |
| Value | 46 | 40 |
| Quality | 56 | 36 |
| Growth | 47 | 48 |
| Safety | 32 | 41 |
| Sentiment | 44 | 64 |
| Quality details | ||
| Profitability | 55 | 38 |
| Cash Truth | 56 | 34 |
Bora Pharmaceuticals vs BoryungBora Pharmaceuticals vs Kukje PharmaBora Pharmaceuticals vs Reyon PharmaceuticalBora Pharmaceuticals vs Kyongbo PharmaceuticalAdd a third stock →
Full analyses: Bora Pharmaceuticals · Hanall Biopharma
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100